Chronic Kidney Disease Trial, Recruiting NCT07626710 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07626710
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People over 18 years old with a life expectancy of more than one year
  • People who have been recommended for a minimally invasive heart valve replacement procedure (called TAVI) by a specialist medical team
  • People who had at least one medical imaging scan using contrast dye (a special fluid used to make scans clearer) in the two months before the TAVI procedure
  • People who had their kidney function measured after each contrast dye scan, including after the TAVI procedure, with at least three measurements taken within the five days following each procedure
  • People who have been informed about anonymous data collection for research purposes and have provided written consent — either consent to the procedure itself (for patients before 2018) or consent to the research purposes of the medical centre (for patients from 2018 onward)

Who may not be able to join:

  • Women who are pregnant, able to become pregnant, or currently breastfeeding
  • People with severely reduced kidney function, defined by a specific kidney filtration measurement below a certain threshold (confirm with trial site)
  • People who are planned to start dialysis (a treatment that does the work of the kidneys)
  • People with other serious health conditions that could interfere with completing the study, or who have a life expectancy of less than one year
  • People who do not have complete kidney function measurements recorded after each contrast dye procedure
  • People currently taking part in another clinical trial for an investigational drug or device that has not yet finished, or that could interfere with this study's results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Enrico Romagnoli, Fondazione Policlinico Universitario Agostino Gemelli

Phone: +390630154187

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 August 2024
Est. completion
30 August 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Rate of Contrast-induced acute kidney injuy; Rate of 1-year mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov